DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Bansilal S, Bloomgarden Z, Halperin JL. , et al; ROCKET AF Steering Committee and Investigators.
Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).
Am Heart J 2015;
170 (04) 675-682
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.